Summary
Updated Aug 31, 2026
Target N. V. Biotech files SEC Form 4 reports at Molecular Templates, Inc. (MTEM). 1 SEC Form 4 filing on record, dated 18 November 2024. Most recent open-market trade: sold $846K of MTEM on 18 November 2024. Lifetime open-market purchases: $412K. Lifetime open-market sales: $846K.
Recent Transactions
1Every recent SEC Form 4 transaction Target N. V. Biotech has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Target N. V. Biotech go back to 2024: 1 primary Form 4 filing, an average of 0.3 per year. The typical open-market purchase is $206K (2 buys totaling $412K). The largest single buy on record is $316K of MTEM in 2024. Sales side: 1 recorded sale totaling $846K, so the filing history runs sell-heavy by dollar value. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Sector
No other insider has filed at Target N. V. Biotech's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Gary S. Guthart - $48.79M of ISRG open-market activity in the last 12 months
- Robert B. Ford - $48.22M of ABT open-market activity in the last 12 months
- Daniel Patrick O'Day - $47.86M of GILD open-market activity in the last 12 months
- Roger Adsett - $47.51M of INSM open-market activity in the last 12 months
- Bihua Chen - $46.87M of MLTX open-market activity in the last 12 months
- Mario Schlosser - $46.37M of OSCR open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Target N. V. Biotech?
Target N. V. Biotech is a corporate insider of Molecular Templates, Inc. (MTEM). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Target N. V. Biotech last file a Form 4?
The only primary Form 4 on record is dated 18 November 2024.
Has Target N. V. Biotech been buying or selling stock?
Recorded transactions: 2 open-market purchases ($412K) and 1 open-market sale ($846K) across all tracked filings.
Where can I see all of Target N. V. Biotech's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Target N. V. Biotech and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial